Clinical Trial Update: Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial evaluating angiogenic and EGFR blockade in combination with curative chemoradiation for advanced head and neck cancer. The study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Pharyngeal Cancer

Snippet

Sponsor: David M. Brizel, MD | Conditions: Head and Neck Cancer, Pharynx Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2011-08-31